Johnson & Johnson names Tom Cavanaugh to succeed Jennifer Taubert in 2026

Taubert will retire after more than 21 years at the company, where she led Innovative Medicine to more than $60 billion in annual revenue.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.